NEW YORK (GenomeWeb News) – Genetic test developer DxNA said today that the US Food and Drug Administration has granted Emergency Use Authorization (EUA) for the firm's PCR-based test for 2009 H1N1 influenza.

The EUA for DxNA's GeneSTAT detection platform is a legal means that allows FDA to authorize new medical devices during medical emergencies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.